Post Test and Evaluation
Please note that to receive credit you must achieve a score of at least 70%.
Certificate of Credit will be emailed within 4 weeks of successful completion of the activity.
Post-Activity Test
1.
Which of the following Candida species exhibits the greatest intrinsic resistance against the azoles?
(Required.)
C. tropicalis
C. glabrata
C. parapsilosis
C. lusitaniae
2.
Mutations in the cyp51A gene in Aspergillus has been shown to be associated with resistance against:
(Required.)
Echinocandins
Polyenes
Azoles
Flucytosine
3.
A 54-year-old female patient with AML is admitted for induction chemotherapy. She is given fluconazole and cefepime prophylaxis. Seven days later while still receiving prophylactic therapy, she develops cough, fever, and rash on her extremities. PNA-FISH analysis of a blood sample reveals the presence of Candida. Which of the following is the most appropriate option?
(Required.)
Increase the dose of fluconazole
Switch to voriconazole therapy
Switch to an echinocandin
Wait for susceptibility results before adjusting therapy
4.
Antifungal prophylaxis with all of the following agents provides protection against molds except:?
(Required.)
Fluconazole
Voriconazole
Posaconazole
Micafungin
5.
Appropriate samples that can be used to identify Aspergillus infection via galactomannan EIA include:
(Required.)
Serum
BAL
Sputum
All of the above
Serum and BAL Only
6.
The Fungitell Beta-D-glucan assay can be used to detect infections caused by:
(Required.)
Cryptococcus neoformans
Aspergillus spp.
Zygomycetes
Staphylococcus spp.
7.
Therapeutic drug monitoring is recommended with the use of:
(Required.)
Fluconazole
Voriconazole
Micafungin
All of the above
8.
IDSA currently recommends first-line treatment of pulmonary aspergillosis with:
(Required.)
Anidulafungin
Voriconazole
Posaconazole
Amphotericin B
9.
Appropriate treatment of mucormycosis in a 24-year-old patient following an allogeneic bone marrow transplantation who is currently taking immunosuppressive medication is:
(Required.)
Voriconazole
Caspofungin
High-dose lipid formulation of amphotericin B
Fluconazole plus an echinocandin
10.
In a clinical study comparing voriconazole with isavuconazole for the treatment of aspergillosis and mold infections, compared to voriconazole use, isavuconazole treatment was shown to result in:
(Required.)
Significantly lower 6-week mortality rates
Significantly higher success rates at end of therapy
Statistically fewer drug-related adverse events
All of the above